Cargando…

Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis

Detalles Bibliográficos
Autores principales:	Shen, Weiran, Liu, Shengjiang, Ou, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891283/ https://www.ncbi.nlm.nih.gov/pubmed/36741359 http://dx.doi.org/10.3389/fimmu.2022.1104646

Ejemplares similares

rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
por: Shen, Weiran, et al.
Publicado: (2022)

Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
por: Chu, Wing Sum, et al.
Publicado: (2021)

Editorial: Immunogenicity and toxicity of AAV gene therapy
por: Bradbury, Allison, et al.
Publicado: (2023)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)

Immunogenicity and toxicity of AAV gene therapy
por: Ertl, Hildegund C. J.
Publicado: (2022)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021)

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19
por: Esmagambetov, Ilias B., et al.
Publicado: (2023)

Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
por: Osting, Sue, et al.
Publicado: (2014)

Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors
por: Ferrand, Maxime, et al.
Publicado: (2015)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020)

Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
por: Bieber, Scott, et al.
Publicado: (2013)

rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021)

VectorMOD: Method for Bottom-Up Proteomic Characterization of rAAV Capsid Post-Translational Modifications and Vector Impurities
por: Rumachik, Neil G., et al.
Publicado: (2021)

Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back
por: Buscara, Laurine, et al.
Publicado: (2020)

Monobac System–A Single Baculovirus for the Production of rAAV
por: Galibert, Lionel, et al.
Publicado: (2021)

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
por: Rao, Renuka, et al.
Publicado: (2022)

Subcellular distribution of the rAAV genome depends on genome structure
por: Oh, Nuri, et al.
Publicado: (2023)

Optimization of miR-22 expression cassette for rAAV delivery on diabetes
por: Yang, Li, et al.
Publicado: (2022)

rAAV-compatible MiniPromoters for restricted expression in the brain and eye
por: de Leeuw, Charles N., et al.
Publicado: (2016)

Computational and molecular tools for scalable rAAV-mediated genome editing
por: Stoimenov, Ivaylo, et al.
Publicado: (2015)

Liver targeting with rAAV7: balancing tropism with immune profiles
por: Flotte, Terence R.
Publicado: (2021)

rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing
por: Iglesias, Cristovão Freitas, et al.
Publicado: (2023)

Construction of an rAAV Producer Cell Line through Synthetic Biology
por: Lee, Zion, et al.
Publicado: (2022)

rAAV-PHP.B escapes the mouse eye and causes lethality whereas rAAV9 can transduce aniridic corneal limbal stem cells without lethality
por: Mirjalili Mohanna, Seyedeh Zeinab, et al.
Publicado: (2023)

Enriched Environment Cues Suggest a New Strategy to Counteract Glioma: Engineered rAAV2-IL-15 Microglia Modulate the Tumor Microenvironment
por: Mormino, Alessandro, et al.
Publicado: (2021)

Long term physiologic modification using rAAV in utero gene-therapy
por: Garrett, Deiadra J, et al.
Publicado: (2004)

Neuroprotection by rAAV-mediated gene transfer of bone morphogenic protein 7
por: Heinonen, Ann-Marie, et al.
Publicado: (2014)

Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors
por: Dong, Biao, et al.
Publicado: (2014)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

Intravenous rAAV2/9 injection for murine cochlear gene delivery
por: Shibata, Seiji B., et al.
Publicado: (2017)

Effects of Thermally Induced Configuration Changes on rAAV Genome’s Enzymatic Accessibility
por: Xu, Yinxia, et al.
Publicado: (2020)

rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application
por: Blanc, Fabian, et al.
Publicado: (2020)

Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice
por: Mulcrone, Patrick L., et al.
Publicado: (2022)

An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
por: Tkatch, Tatiana, et al.
Publicado: (2022)

A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7 In Vivo
por: Gondé, Henri, et al.
Publicado: (2021)

An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases
por: Luo, Tao, et al.
Publicado: (2022)

The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
por: Gonzalez-Sandoval, Adriana, et al.
Publicado: (2023)

The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector
por: Li, Rilun, et al.
Publicado: (2013)

The MRI Contrast Agent Gadoteridol Enhances Distribution of rAAV1 in the Rat Hippocampus
por: Hullinger, Rikki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qkilnukef062u8dksgqk9s6fqr